ImmunityBio’s Anktiva shows promising revenue growth with upcoming FDA decisions and clinical trial results that could expand its cancer treatment franchise.
Discover how Fed interest rate decisions influence SaaS company valuations and how software stocks react to rate changes and policy shifts.
Analyze Straco Corporation’s 2026 de-rating driven by cyclical visitor trends, revenue impacts, and what investors should monitor in tourism recovery efforts.
Explore BitMart’s impressive H1 2026 asset growth amid crypto price declines, with insights into product expansion, trust, and industry implications.
Explore the dynamics of Powerball jackpots in 2026, understanding odds, market impact, and strategies for players amid record rollovers and global expansion.
Learn how SEC filings like 10-Ks and 10-Qs transform tech stock analysis, revealing revenue streams, margins, and risks beyond headlines for smarter investing.
Learn how engineering teams can apply financial analysis tools like NPV, TCO, and build-vs-buy models to improve infrastructure decisions in 2026.
Explore the evolving landscape of AI in finance, examining recent regulatory changes, model accuracy benchmarks, and the shift toward human oversight in 2026.
Discover how the open-source GLM 5.2 model approaches human accuracy in structured tasks like bookkeeping, with insights on architecture, costs, and…
Analyzes TCC investment stories in 2026, highlighting demand recovery and storage project execution, with macro and sector insights for investors.
An in-depth analysis of Cochlear Ltd.’s stock de-rating, recovery prospects, and the role of AI advancements in hearing implant technology, guiding investor…
Learn to analyze public tech filings in 2026 with a comprehensive framework, connecting segment economics, margins, guidance, and infrastructure investments.